FDA Inspection 1084681 — Blythe Enterprises Inc
The FDA completed an inspection of Blythe Enterprises Inc on March 14, 2019 in Hoschton, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 14, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Hoschton, GA (United States)